| Market Cap | ₹44,381Cr |
| ROE | 55.94% |
| P/E Ratio(TTM) | 43.47 |
| EPS(TTM) | 60.27 |
| P/B Ratio | 25.99 |
| Dividend Yield | 2.06% |
| Industry P/E | 32.40 |
| Book Value | 100.80 |
| Debt to Equity | 0.02 |
| Face Value | 10 |
| Managing Director | Bhushan Akshikar |
| Founded | 1924 |
| NSE Symbol | GLAXO |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Abbott India | NA (0.00%) | 38.47 | ||
| Pfizer | NA (0.00%) | 27.06 | ||
| Astrazeneca Pharma India | NA (0.00%) | 112.41 | ||
| Sanofi Consumer Healthcare India | NA (0.00%) | 44.99 |